| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
( Department of Pharmacology, Yale University School of Medicine, New Haven, Conn.)
The fate of 6-uracil methyl sulfone in a liver homogenate has been studied with both chemical methods of assay and radioactivity measurements. The drug is metabolized by a nonenzymatic attack of sulfhydryl-containing compounds with a resultant loss of the -SO2CH3 group and the formation of a derivative of uracil in which the sulfurcontaining compound is exchanged for the group displaced.
Received 5/29/58.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |